Explore services by industry
    Clinicians reviewing brain imaging for a neurology device study

    Your CRO for Neurology Medical Devices

    Clinical evidence for stroke, neurovascular, neuromodulation and neuro-monitoring devices

    Neurology device studies bring their own clinical and operational challenges, from treatment windows measured in minutes to consent in patients who cannot give it, sham-controlled designs and long-term follow-up of active implants. QbD Group combines medical device CRO execution with regulatory and scientific expertise to build the evidence for your neurological device, from strategy to post-market follow-up.

    Neurological Endpoints

    A CRO Dedicated to Neurology Devices

    A neurology medical device CRO is a contract research organisation that designs and runs clinical investigations for devices that diagnose, monitor or treat conditions of the brain, spinal cord and nerves. QbD Clinical is a European CRO that works only on medical devices, IVD and companion diagnostics, with neurology as one of three core therapeutic areas. Over the past five years we have supported 49 NeuroTech clinical trials.

    We support stroke and neurovascular devices, neurostimulation and neuromodulation systems, epilepsy technologies, neuro-monitoring and diagnostic devices, and neurology software (SaMD), from first-in-human and pivotal investigations through post-market clinical follow-up (PMCF).

    Our objective is to generate the evidence you need for EU MDR compliance, FDA submissions and your next development milestone, through study designs that are scientifically sound and workable at the bedside.

    Neurology Track Record

    49

    NeuroTech clinical trials supported in the past five years

    23

    Epilepsy trials

    8

    Cerebrovascular disease and stroke trials

    28

    Trials involving implantable and reconstructive devices

    Pivotal, first-in-human and post-market experience across Europe and the US, including a 277-subject pivotal stroke study.

    Protocol Details

    The Realities We Design For in Neurology Studies

    Neurology trials succeed or fail on details a generalist CRO can miss. We plan for them from day one.

    Time-Critical Enrolment

    In an untreated acute ischaemic stroke, around 1.9 million neurons are lost every minute. We build screening, randomisation and site workflows that fit inside the emergency pathway, not around it.

    Consent in Emergency and Incapacitated Patients

    EU MDR sets specific rules for investigations in emergency situations (Article 68), incapacitated subjects (Article 64) and minors (Article 65). We design consent and deferred-consent procedures that ethics committees and national authorities accept.

    Neuro-Specific Endpoints

    Functional and clinical scales such as the modified Rankin Scale (mRS), NIHSS and reperfusion grades (mTICI), seizure diaries and validated quality-of-life measures, measured consistently across sites.

    Imaging and Core Labs

    CT, MRI and angiography assessments aligned through core-lab reading, so imaging endpoints stay consistent between centres and countries.

    Sham Control and Blinding

    Neuromodulation and neurostimulation studies often need sham arms and blinded assessors. We design control strategies that hold up to scrutiny from Notified Bodies and the FDA.

    Long-Term Follow-Up of Active Implants

    Implanted neurostimulators and neurovascular implants are usually Class III. We plan PMCF, device performance tracking and safety reporting for the full life of the implant.

    Connected Device Disciplines

    The Full MedTech Evidence Package, Under One Roof

    Neurology devices increasingly combine an implant or catheter with software, connectivity and AI. QbD Group brings the disciplines together, so you are not stitching vendors together across the lifecycle.

    Clinical CRO

    Study design, operations, monitoring, imaging coordination, data management and CSR.

    Regulatory Affairs

    EU MDR strategy, Notified Body coordination, CER and PMCF, authority and ethics submissions.

    Quality Assurance

    QMS, ISO 13485 and audit-ready documentation.

    Software and SaMD

    IEC 62304, validation and AI-enabled software for neuro-monitoring and diagnostics.

    EU Legal Representative

    For non-EU sponsors running clinical investigations in Europe.

    Stroke and Neurotechnologies

    Neurology Client Cases

    Neuro | Stroke

    • Indication

      Acute ischaemic stroke / aspiration catheters
    • Study Type

      Pivotal interventional study
    • Regions

      European Union | United States
    • Subjects

      277 forecasted
    • Services

      Full CRO services, regulatory submissions, biostatistics, data management

    Neuro | Epilepsy

    • Indication

      Drug-resistant epilepsy, Vagus Nerve Stimulation (VNS) registry
    • Study Type

      Global post-market registry, ongoing since 2018
    • Regions

      Global, including Australia, Brazil and Europe
    • Services

      Global project management, site oversight, local and central IRB coordination, CRA monitoring network, technical VNS output review, CSR medical writing

    Neuro | Neurostimulation

    • Indication

      Chronic low back pain, implantable neurostimulation
    • Study Type

      Pivotal trial, preceded by FIH and followed by PMCF
    • Regions

      Belgium | Netherlands | United Kingdom (+ Germany for PMCF)
    • Subjects

      208 enrolled across 40 sites, FDA PMA approval
    • Services

      Full CRO services, regulatory submissions, monitoring, site management

    Neuro | Movement Disorders

    • Indication

      Dystonia and tinnitus
    • Study Type

      First-in-human / premarket study
    • Subjects

      11 patients
    • Outcome

      CE marked
    • Regions

      [PLACEHOLDER – Movement Disorders case: regions]
    • Services

      [PLACEHOLDER – Movement Disorders case: services]

    Authority Response Experience

    Regulatory Challenges, Resolved

    Where authority questions arose, our experience turned them into fast, compliant outcomes.

    Study-Design Bias Concerns in a High-Risk FIH Investigation

    Challenge: The Belgian Competent Authority (FAGG) raised concerns about potential bias in the design of a high-risk first-in-human investigation.

    QbD Group Solution: We addressed the study-design concerns and set up a Data Safety Monitoring Board (DSMB) to provide independent oversight.

    Outcome:

    Competent Authority feedback resolved.

    [PLACEHOLDER – Study-design bias case: final outcome confirmation with Sarah]

    Rejected Submission Package

    Challenge: A clinical investigation submission was rejected as incomplete.

    QbD Group Solution: We rapidly completed the package, including updated insurance certificates, ICF updates and PI clarifications.

    Outcome: Conditional approval, followed by Substantial Amendment approval.

    Scientific Counsel

    Meet the Medical Advisory Board

    Our Medical Advisory Board brings together experienced life sciences professionals who provide expert guidance on clinical strategy, patient safety, scientific rigour, and regulatory compliance.

    Lieven Lagae, Full Professor and Head of Paediatric Neurology

    Lieven Lagae

    Full Professor & Head of Paediatric Neurology

    • Head of the Paediatric Neurology Department at University Hospitals Leuven, founding Director of the Childhood Epilepsy Center
    • Past President of the European Paediatric Neurology Society, Steering Committee member of EpiCare (European Reference Network for Rare and Complex Epilepsies)
    • Clinical and research focus on childhood epilepsy, including Dravet syndrome and refractory epilepsy treatments

    Areas of Expertise

    QbD Clinical’s Independent Medical Advisory Board

    1. Strategic & Scientific Advice

    2. Clinical Study Support

      • •Input study design/protocol
      • •Act as independent Medical Monitor
      • •Act as CEC/DSMB member
    3. Clinical Evidence Support

      • •Clinical Development planning
      • •Support Risk assessment
      • •Validate clinical relevance
    4. Therapeutic Training for QbD Group Employees

    End-to-End Delivery

    Neurology Study Workstreams

    Build the right evidence package from study design to PMCF, with QbD Group’s clinical, regulatory and wider MedTech expertise under one roof.

    01

    Feasibility, Site and Investigator Strategy

    02

    Protocol, Endpoints and Clinical Strategy

    03

    Regulatory Submissions and Ethics, Including Emergency Consent

    04

    Clinical Safety Management, CEC and DSMB

    05

    Monitoring and Clinical Trial Operations

    06

    Imaging Core Lab Coordination and Data Management

    07

    Biostatistics, Analysis and Medical Writing

    08

    CER, PMCF and Post-Market Evidence

    On-Demand Webinar

    The Emergency Room Reality of Neurology Device Trials

    Sponsor Planning Guidance

    Neurology Device Clinical Trials: Common Questions

    [PLACEHOLDER – Related neurology resources (approved titles, links and images)]

    Build a Neurology Evidence Strategy Fit for Your Next Milestone

    Whether you are refining your clinical strategy or launching a pivotal stroke or neuromodulation study, our clinical and regulatory experts are ready to support your MedTech journey, from gap assessment to full CRO delivery.